Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,822,000
-$3,788,000 QoQ
Shares Held
4,300,000
-21.8% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,595,586,445 across 121 Biotechnology names. ANNX ranks #41 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,475,611 | $532,503,169 | |
| 2 | RPRX |
Royalty Pharma plc
|
7,480,633 | $358,845,965 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
8,925,010 | $354,501,397 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
12,794,097 | $354,396,486 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
12,809,485 | $267,974,426 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
815,739 | $262,822,948 | |
| 7 | INSM |
INSMED Inc
|
900,000 | $147,168,000 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
737,578 | $124,665,433 |
All Filings in ANNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,822,000 | 4,300,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,610,000 | 5,500,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,575,000 | 1,500,000 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $16,813,658 | 2,840,145 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,916,710 | 2,840,145 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $30,974,220 | 4,319,975 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $22,699,886 | 4,999,975 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,545,941 | 2,349,975 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,271,912 | 2,349,975 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $13,667,403 | 3,549,975 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,353,370 | 3,549,975 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $22,204,585 | 3,592,975 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,602,725 | 955,630 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,620,335 | 959,830 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,028,446 | 959,830 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,792,936 | 1,009,830 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $21,605,773 | 959,830 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $28,113,667 | 1,009,830 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $25,276,044 | 1,009,830 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $33,550,160 | 1,109,830 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||